Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat

Pharmacology. 1987;35(4):194-202. doi: 10.1159/000138311.

Abstract

Cardiovascular responses to sustained infusion of quinpirole (LY171555), a dopamine (DA) D2 receptor agonist, and bolus injection of quinpirole following sustained infusion were examined in conscious, unrestrained Sprague-Dawley rats to investigate the contributions of central and peripheral D2 receptors to the regulation of cardiovascular function. Continuous intravenous administration of quinpirole induced a transient pressor response followed by normalization of mean arterial pressure (MAP) and, at higher doses, a decrease in MAP below control levels. Intravenous bolus injections of quinpirole administered 30 min after termination of the infusion produced dose-dependent depressor responses which were blocked by pretreatment with domperidone, a peripheral D2 antagonist. The data suggest that continuous intravenous administration of quinpirole produces a transient centrally mediated pressor effect which is followed by a more sustained, peripherally mediated depressor response.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arginine Vasopressin / blood
  • Blood Pressure / drug effects*
  • Catecholamines / blood
  • Domperidone / pharmacology
  • Dose-Response Relationship, Drug
  • Ergolines / pharmacology*
  • Heart Rate / drug effects
  • Male
  • Quinpirole
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine / drug effects*
  • Receptors, Dopamine D2

Substances

  • Catecholamines
  • Ergolines
  • Receptors, Dopamine
  • Receptors, Dopamine D2
  • Arginine Vasopressin
  • Quinpirole
  • Domperidone